Using ultrasound to improve detection of fetal growth issues
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth (Oxford Growth Restriction Identification Programme (OxGRIP)) on Risk Factors for and the Incidences of Adverse Maternal, Fetal and Neonatal Outcome
This study is trying to see if using ultrasound in a structured way can help doctors better spot babies that are not growing properly during pregnancy to reduce the risk of stillbirth.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 56000 (estimated) |
| Ages | 16 Years to 60 Years |
| Sex | Female |
| Sponsor | Oxford University Hospitals NHS Trust Academic / other |
| Locations | 1 site (Oxford, Oxfordshire) |
| Trial ID | NCT03662178 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the structured use of ultrasound scanning to enhance the detection of fetal growth restriction during pregnancy. It focuses on the Oxford Growth Restriction Pathway (OxGRIP), which aims to improve the identification of growth-restricted babies, a significant risk factor for stillbirth. The study analyzes routinely collected clinical data from pregnant women receiving antenatal care at the Oxford University Hospitals NHS Foundation Trust over a six-year period. By evaluating the effectiveness of this clinical care pathway, the study seeks to address the current low detection rates of fetal growth issues.
Who should consider this trial
Good fit: Ideal candidates for this study are all pregnant women receiving antenatal care at the Oxford University Hospitals NHS Foundation Trust.
Not a fit: Patients who have opted out of research related to pregnancy during their care at the OUHFT may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the rates of stillbirth by improving the detection of growth-restricted fetuses.
How similar studies have performed: Other studies have shown that structured pathways can improve detection rates of fetal growth issues, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • All pregnant women receiving antenatal care at the Oxford University Hospitals NHS Foundation Trust (OUHFT) from January 2013 to 31st December 2019 with no exclusion criteria Exclusion Criteria: * Women who have opted out of research related to pregnancy in this pregnancy whilst receiving care by the OUHFT. * If intrapartum care takes place outside of the OUHFT.
Where this trial is running
Oxford, Oxfordshire
- Oxford University Hospitals NHS Foundation Trust — Oxford, Oxfordshire, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Lawrence Impey
- Email: lawrence.impey@ouh.nhs.uk
- Phone: 01865 851165
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.